Insights

Deal Insights

Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools

Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools

Learn More

Deal Insights

Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business

Actigraph, a Portfolio Company of Archimed, acquired Biofourmis Connect, a Division of Biofourmis, to Establish a Software and Data Ecosystem for Clinical Research Throughout the Drug-product Lifecycle and Across Therapeutic Areas

Learn More

BlueBook

Diagnostics and Tools BlueBook December 2024

Highlights from this edition: Navis Clinical Laboratories was acquired by Wildcat DX, Surgical Science announced its acquisition of Intelligent Ultrasound, Pleno closed a $25 Series A Financing, led by Deerfield Management, Foresite Capital, and Medical Excellence Capital

Download Now

BlueBook

Pharma Services: Pharmaceutical Commerce BlueBook December 2024

Highlights from this edition: Realyze Intelligence was acquired by Carta Healthcare, Kester Capital announced its acquisition of Emas Pharma, Cleerly closed a $298 Series A Financing, led by Battery Ventures, Insight Venture Management, and LRVHealth

Download Now

BlueBook

Pharma Services: Drug Supply Chain BlueBook December 2024

Highlights from this edition: Patterson Companies was acquired by Patient Square Capital, LSL Pharma Group announced its acquisition of Dermolab Pharma, Laurus Labs closed a $14 Series A Financing, led by Eight Roads Ventures and Impresa Management

Download Now

BlueBook

Pharma Services: Drug Development BlueBook December 2024

Highlights from this edition: Insite Clinical Research was acquired by Adams Clinical, Kester Capital announced its acquisition of Emas Pharma, Databricks closed a $10,175MM Series A Financing, led by Insight Venture, Wellington Management, and GIC

Download Now

/ 6